Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids

Acta Ophthalmologica

Volumn 91, Issue 6, 2013, Pages

  Abu El Asrar, Ahmed M ^a   Al Tamimi, Mamdouh ^a   Hemachandran, Suhail ^a   Al Mezaine, Hani S ^a   Al Muammar, Abdulrahman ^a   Kangave, Dustan ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

complications; immunomodulatory therapy; outcome; Vogt Koyanagi Harada disease

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGE; ANTERIOR EYE SEGMENT; ARTICLE; CATARACT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; EYE INFLAMMATION; EYE SYNECHIA; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; IMMUNOMODULATION; IRIS DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETINA DETACHMENT; RETROSPECTIVE STUDY; VISUAL ACUITY; VOGT KOYANAGI SYNDROME;

COMPLICATIONS; IMMUNOMODULATORY THERAPY; OUTCOME; VOGT-KOYANAGI-HARADA DISEASE;

ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UVEOMENINGOENCEPHALITIC SYNDROME; VISUAL ACUITY; YOUNG ADULT;

EID: 84882573855     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12127     Document Type: Article

References (26)

1. Abu El-Asrar AM, Al-Kharashi AS, Aldibhi H, Al-Fraykh H, &, Kangave D, (2008): Vogt-Koyanagi-Harada disease in children. Eye (Lond) 22: 1124-1131.
2. Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, &, Al-Muammar AM, (2012): The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmol 90: e603-e608.
3. Al-Kharashi AS, Aldibhi H, AL-Fraykh H, Kangave D, &, Abu El-Asrar AM, (2007): Prognostic factors in Vogt-Koyanagi-Harada disease. Int Ophthalmol 27: 201-210. (Pubitemid 46909262)
4. Al-Mezaine HS, Kangave D, &, Abu El-Asrar AM, (2010): Patterns of uveitis in patients admitted to a university hospital in Riyadh, Saudi Arabia. Ocul Immunol Inflamm 18: 424-431.
5. Bacsal K, Wen DS, &, Chee SP, (2008): Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 145: 480-486.
6. Chee S-P, Jap A, &, Bacsal K, (2007): Spectrum of Vogt-Koyanagi-Harada disease in Singapore. Int Ophthalmol 27: 137-142. (Pubitemid 46909253)
7. Chee SP, Jap A, &, Bacsal K, (2009): Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Am J Ophthalmol 147: 154-161.
8. Cuchacovich M, Solanes F, Diaz G, et al., (2010): Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm 18: 200-207.
9. Errera MH, Fardeau C, Cohen D, Navarro A, Gaudric A, Bodaghi B, Westcott M, &, LeHoang P, (2011): Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt-Koyanagi-Harada disease. Acta Ophthalmol 89: e357-e366.
10. Fang W, &, Yang P, (2008): Vogt-Koyanagi-Harada syndrome. Curr Eye Res 33: 517-523. (Pubitemid 351948483)
11. Fang W, Zhou H, Yang P, Huang X, Wang L, &, Kijlstra A, (2008): Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 92: 182-185. (Pubitemid 351224091)
12. Gocho K, Kondo I, &, Yamaki K, (2001): Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 42: 2004-2009. (Pubitemid 32726031)
13. Inomata H, &, Sakamoto T, (1990): Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus. Curr Eye Res 9 (Suppl): 35-40. (Pubitemid 20295598)
14. Kawaguchi T, Horie S, Bouchenaki N, Ohno-Matsui K, Mochizuki M, &, Herbort CP, (2010): Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease. Int Ophthalmol 30: 41-50.
15. Keino H, Goto H, &, Usui M, (2002): Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation. Graefes Arch Clin Exp Ophthalmol 240: 878-882. (Pubitemid 36075647)
16. Kim SJ, &, Yu HG, (2007): The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm 15: 381-387. (Pubitemid 350035481)
17. Lai TY, Chan RP, Chan CK, &, Lam DS, (2009): Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye (Lond) 23: 543-548.
18. Moorthy RS, Inomata H, &, Rao NA, (1995): Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 39: 265-292.
19. Ohno S, Minakawa R, &, Matsuda H, (1988): Clinical studies of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 32: 334-343.
20. Paredes I, Ahmed M, &, Foster CS, (2006): Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm 14: 87-90.
21. Read RW, Holland GN, Rao NA, et al., (2001a): Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131: 647-652. (Pubitemid 32422124)
22. Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, &, Rao NA, (2001b): Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 131: 599-606. (Pubitemid 32422116)
23. Rubsamen PE, &, Gass JD, (1991): Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 109: 682-687.
24. Yamaki K, Gocho K, Hayakawa K, Kondo I, &, Sakuragi S, (2000a): Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 165: 7323-7329. (Pubitemid 32001213)
25. Yamaki K, Kondo I, Nakamura H, Miyano M, Konno S, &, Sakuragi S, (2000b): Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res 71: 361-369.
26. Yang P, Ren Y, Li B, Fang W, Meng Q, &, Kijlstra A, (2007): Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 114: 606-614.